S&P soars to best week of 2024 as Wall Street gears up for anticipated interest rate cuts
https://seekingalpha.com/news/4149768-sp-soars-to-best-week-of-2024-as-wall-street-gears-up-for-anticipated-interest-rate-cuts?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Sep 13, 2024 - The S&P 500 (SP500) on Friday surged 4.02% for the week to end at 5,626.02 points, posting gains in all five sessions. Read more here.
0
Arcus up 4% following Merck Welireg kidney cancer data
https://seekingalpha.com/news/4149696-arcus-up-4-following-merck-welireg-kidney-cancer-data?source=feed_sector_healthcare
Sep 13, 2024 - Shares of Arcus Biosciences (RCUS) rise as Merck's data on Welireg disappoints in type of kidney cancer. Read more here.
0
Is Kohl's Setting Up For A Monster Short Squeeze?
https://seekingalpha.com/article/4720848-is-kohls-kss-stock-setting-up-for-a-monster-short-squeeze?source=feed_all_articles
Sep 12, 2024 - Short sellers have heavily targeted Kohl's in 2024, with short interest ballooning to 36% of diluted shares. Read here to know why we rate KSS stock a buy.
0
Markets Up for the Week (So Far) on Inflation and Jobs
https://www.zacks.com/stock/news/2335569/markets-up-for-the-week-so-far-on-inflation-and-jobs?cid=CS-ZC-FT-ahead_of_wall_street-2335569
Sep 12, 2024 - On the path to a lower Fed funds rate next week for the first time in years, CPI, PPI and Jobless Claims numbers performed decently.
0
Chewy Stock Up 23% in a Month: Is it Time to Buy, Hold or Cash Out?
https://www.zacks.com/stock/news/2335490/chewy-stock-up-23-in-a-month-is-it-time-to-buy-hold-or-cash-out?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2335490
Sep 12, 2024 - Chewy has firmed its position in online pet retail, leveraging its Autoship program and expanding veterinary services to drive growth and long-term stability.
0
AEM Stock, Riding Gold Price Rally, Up 41%: Buy, Sell or Hold?
https://www.zacks.com/stock/news/2335491/aem-stock-riding-gold-price-rally-up-41-buy-sell-or-hold?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2335491
Sep 12, 2024 - While AEM is well-placed on a strong pipeline of growth projects, solid financial health and a healthy growth trajectory, its high costs warrant caution.
0
TAN: Trump Nor Harris Will Save Solar - It Is Up To Jerome Powell
https://seekingalpha.com/article/4720777-tan-trump-nor-harris-will-save-solar-it-is-up-to-jerome-powell?source=feed_tag_etf_portfolio_strategy
Sep 12, 2024 - The Invesco Solar fund underperformed due to its market-cap weighting system, which tends to buy high and sell low. Learn more about TAN ETF here.
0
CNO Financial Up 19.6% in 3 Months: Will You Regret Not Buying in?
https://www.zacks.com/stock/news/2335429/cno-financial-up-19-6-in-3-months-will-you-regret-not-buying-in?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2335429
Sep 12, 2024 - CNO invests significantly in technology to improve agent productivity and sales.
0
Dycom Stock Up 61% YTD: Lock in Gains or Hold for More Upside?
https://www.zacks.com/stock/news/2335428/dycom-stock-up-61-ytd-lock-in-gains-or-hold-for-more-upside?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2335428
Sep 12, 2024 - Can the strong demand for telecommunications infrastructure push DY stock higher?
0
Why Is Fate Therapeutics (FATE) Up 18.7% Since Last Earnings Report?
https://www.zacks.com/stock/news/2335353/why-is-fate-therapeutics-fate-up-18-7-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2335353
Sep 12, 2024 - Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0